Followers | 813 |
Posts | 71327 |
Boards Moderated | 2 |
Alias Born | 01/30/2003 |
Tuesday, May 12, 2015 5:24:40 PM
Date : 05/12/2015 @ 4:02PM
Source : Edgar (US Regulatory)
Stock : Amfil Technologies Inc. (PN) (AMFE)
Quote : 0.0076 0.0 (0.00%) @ 4:02PM
Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)
Alert
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 033-02775-A
AMFIL TECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)
3601 HWY 7, Suite # 400, Markham, Ontario, Canada L3R 0M3 (647) 880-5887
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
COMMON STOCK $.001 PAR VALUE
(Title of each class of securities covered by this Form)
NONE
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) o
Rule 12g-4(a)(2) þ
Rule 12h-3(b)(1)(i) o
Rule 12h-3(b)(1)(ii) o
Rule 15d-6 o
Approximate number of holders of record as of the certification or notice date: 481 as of May 10th 2015
Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: May 11,2015 By: /s/ Roger Mortimer
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM